Skip to content

Application value of beside pupillary ultrasound in early prediction and prognosis assessment of anterior circulation large-area cerebral infarction

Application value of beside pupillary ultrasound in early prediction and prognosis assessment of anterior circulation large-area cerebral infarction

Status
Active, not recruiting
Phases
Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400089540
Enrollment
Unknown
Registered
2024-09-10
Start date
2024-09-10
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral infarction

Interventions

The study group:During the acute phase of cerebral infarction (within 14 days of onset), according to the pupillary ultrasound measurement method and testing plan developed by our research institute,
Control:Receive routine diagnosis and treatment

Sponsors

The First Affiliated Hospital of Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age = 18 years old; 2. Meets the diagnostic criteria for large area cerebral infarction in the anterior circulation (infarction in the middle cerebral artery supply area = 2/3, with or without infarction in the anterior cerebral artery/posterior cerebral artery supply area); 3. The onset time is = 24 hours. 4. Able to sign informed consent forms or obtain family consent.

Exclusion criteria

Exclusion criteria: 1. Any clinically detectable pupil dysfunction or visual field defect; 2. Prior to this onset, there were abnormalities in the optic or oculomotor nerves and their nuclei; 3. Any eye disease (such as glaucoma, cataract, macular degeneration or diabetes retinopathy); 4. Patients with neurological diseases that may cause optic neuropathy or optic atrophy (such as multiple sclerosis, clinically isolated syndrome, optic neuromyelitis spectrum disorder, chronic recurrent inflammatory optic neuropathy, or Leber hereditary optic neuropathy), Or any autoimmune or systemic disease that may have an impact on the autonomic nervous system (such as Guillain Barre syndrome, viral or borderline encephalitis, multiple system atrophy, sarcoidosis, and systemic lupus erythematosus); 5. Patients who have previously undergone any type of ophthalmic surgery or laser treatment; 6. Patients who take local or systemic medications that may affect pupil function before onset. 7. Patients with other neurological or severe systemic diseases; 8. Refusal to participate in this study or inability to cooperate in completing follow-up.

Design outcomes

Primary

MeasureTime frame
Static (indoor natural light):Pupil size, i.e. maximum and minimum aperture (mm);Static (indoor natural light):The difference in pupil diameter on both side;Dynamic (when the pupil is illuminated by light): Latency of light reflection (s);Dynamic (when the pupil is illuminated by light): The speed of pupil contraction and re dilation (mm/s);Percentage change in pupil diameter;

Countries

China

Contacts

Public ContactWang Zhiqiang

The Department of Neurology, the First Affiliated Hospital of Fujian Medical University

wzhq1992@163.com+86 138 0505 9300

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026